People who inject drugs
Globally, around 16 million people inject drugs and 3 million of them are living with HIV. On average, one out of every ten new HIV infections is caused by injecting drug use and in parts of Eastern Europe and Central Asia over 80 per cent of all HIV infections is related to drug use.
WHO strongly supports harm reduction as an evidence-based approach to HIV prevention, treatment and care for people who inject drugs and has defined a comprehensive package, which includes needle and syringe programmes and opioid substitution therapy.
Community management of opioid overdose
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
- WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users – 2012 revision
- Guidelines for the screening, care and treatment of persons with hepatitis C infection
- Guidance on prevention of viral hepatitis B and C among people who inject drugs
“Smart” syringes to help prevent spread of HIV, hepatitis
Early HIV treatment: Tackling HIV among injecting drug users in Vietnam
Young people’s views guide WHO advice on HIV prevention and care for those most at risk
Reaching those at high risk of HIV: how WHO learns from experiences on the ground
- Access to buprenorphine, methadone and oral morphine
- The Reference Group to the UN on HIV and Injecting Drug Use